Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
4
67%
Ph not_applicable
1
17%
Ph phase_2
1
17%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
4(66.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

3 of 6 finished

Non-Completion Rate

50.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(3)

Detailed Status

Completed3
Withdrawn2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (16.7%)
Phase 44 (66.7%)
N/A1 (16.7%)

Trials by Status

completed350%
terminated117%
withdrawn233%

Recent Activity

0 active trials
Showing 5 of 6
completednot_applicable

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

NCT05199714
terminatedphase_4

Carbohydrate Consumption as a Factor in Aspart Dosing

NCT01333514
completedphase_4

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

NCT03336528
completedphase_4

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

NCT04409587
withdrawnphase_4

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

NCT00505882
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05199714Not Applicable

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

Completed
NCT01333514Phase 4

Carbohydrate Consumption as a Factor in Aspart Dosing

Terminated
NCT03336528Phase 4

Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes

Completed
NCT04409587Phase 4

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

Completed
NCT00505882Phase 4

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Withdrawn
NCT00850161Phase 2

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Withdrawn

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6